'Iib iiia' presentation slideshows

James J. Ferguson, MD

James J. Ferguson, MD. The Evolving Standard of Care for Acute Coronary Syndromes. 2006. How do we sort out this mess ?. CAPTURE. PROTECT. EPILOG. EPIC. ISAR-SWEET. GUSTO IIA. SYNERGY. ISAR-REACT. IMPACT 2. ACE. RESTORE. GUSTO IV. TACTICS. CAPRIE. FRIC. BAT. PURSUIT. CADILLAC.

701 views • 60 slides

2007 ESC NSTE-ACS GUIDELINES

2007 ESC NSTE-ACS GUIDELINES. CASE 1: 52-y-o man with previous CABG and typical chest pain at rest since 12 hours. CASE 1: 52-y-o man with previous CABG and typical chest pain at rest since 12 hours CASE 2:

742 views • 54 slides

NSTEMI: GPIIB/IIIA Inhibitors & Emerging Antiplatelets : Where Do We Stand?

NSTEMI: GPIIB/IIIA Inhibitors & Emerging Antiplatelets : Where Do We Stand?. Rabih R. Azar , MD, MSc , FACC Director of Cardiovascular Research Hotel Dieu de France Hospital Associate Professor of Medicine Saint Joseph University School of Medicine Beirut, Lebanon.

754 views • 50 slides

Welcome Ask The Experts March 24-27, 2007 New Orleans, LA

Welcome Ask The Experts March 24-27, 2007 New Orleans, LA. Christopher P. Cannon, MD Senior Investigator, TIMI Study Group Cardiovascular Division Brigham and Women's Hospital Associate Professor of Medicine Harvard Medical School Boston, MA. Year in Review 2006.

595 views • 49 slides

Platelet Structure & Function

Platelet Structure & Function. DR.MOHAMMED ALOTAIBI MRes , PhD (Liverpool, England) Assist. Professor of Physiology, College of Medicine King Khalid University Hospital King Saud University. Objectives. At the end of this lecture the student is expected to:

1.2k views • 47 slides

615 views • 42 slides

ACS-WRAP

ACS-WRAP. Charles V. Pollack, Jr., M.A., M.D., FACEP, FAHA Professor and Chairman Emergency Medicine, Pennsylvania Hospital University of Pennsylvania Health System Philadelphia. Non-ST-Segment-Elevation ACS. Inclusive of unstable angina and NSTEMI

562 views • 41 slides

The Evolving Role of LMWH in ACS

The Evolving Role of LMWH in ACS. James J. Ferguson, MD Texas Heart Institute Houston, TX. Objectives. Assist peers in overcoming gaps in awareness of LMWH therapy in ACS Review emerging data for ACS NICE-3 GUSTO-IV Discuss strategies for increasing early administration of LMWH therapy

498 views • 39 slides

Gregg W. Stone MD for the ACUITY Investigators

Prospective, Randomized Comparison of Routine Upfront Initiation Versus Selective Use of Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes: The ACUITY Timing Trial. Gregg W. Stone MD for the ACUITY Investigators. Disclosure. Gregg W. Stone

476 views • 35 slides

Peripheral Arterial Disease - antiplatelet therapy

653 views • 33 slides

Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE

Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano 9 - 10 aprile 2010. PCI: EARLY AND LATE RESULTS COMPARABLE TO MALE GENDER?. FEDERICA ETTORI SPEDALI CIVILI EMODINAMICA BRESCIA. PTCA IN WOMEN.

481 views • 33 slides

Acute Coronary Syndromes

Acute Coronary Syndromes. Jason Ryan, M.D. UA + NSTEMI (life-threating but not medical emergency). STEMI (medical emergency). Acute Coronary Syndromes. Unstable Angina + Non-ST-Elevation MI + ST-Elevation MI Acute Coronary Syndromes (ACS). Acute Coronary Syndromes.

524 views • 32 slides

ACS

ACS. Rogers Kyle, MD 10/2/12. Learning Objectives. Define Acute Coronary Syndrome (ACS) Review the diagnostic approach to suspected ACS Review the rationale for risk stratification in ACS Outline initial management of ACS Examine antithrombotic options in ACS. Define ACS

737 views • 30 slides

Dr. Harvey White on behalf of the ACUITY investigators

ACUITY PCI A Prospective Trial of Patients with ACS Undergoing PCI after Randomization to Heparin plus GP IIb/IIIa Inhibitors vs. Bivalirudin With or Without GP IIb/IIIa Inhibitors.

344 views • 25 slides

Baseline Characteristics

371 views • 24 slides

Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials

489 views • 22 slides

Gregg W. Stone MD for the ACUITY Investigators

Gregg W. Stone MD for the ACUITY Investigators. A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes Final One-Year Results from the ACUITY Trial. Disclosures. Gregg W. Stone Consultant to The Medicines Company and BMS Imaging

377 views • 22 slides

ATTEMPT study : pooled- A nalysis of T rials on T hromb E ctomy in acute M yocardial infarction based on individual

ATTEMPT study : pooled- A nalysis of T rials on T hromb E ctomy in acute M yocardial infarction based on individual P atien T data. FRANCESCO BURZOTTA INSTITUTE OF CARDIOLOGY CATHOLIC UNIVERSITY OF THE SACRED HEART ROME, ITALY.

271 views • 16 slides

NICE-3 N ational I nvestigators C ollaborating on E noxaparin

NICE-3 N ational I nvestigators C ollaborating on E noxaparin. XXII nd Congress of the European Society of Cardiology August 30, 2000 Amsterdam, The Netherlands. NICE-3 Objectives.

240 views • 14 slides

Gregg W. Stone MD for the ACUITY Investigators

A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes Final One-Year Results from the ACUITY Trial. Gregg W. Stone MD for the ACUITY Investigators. Medical management. UFH/Enox + GP IIb/IIIa (n=4,603). PCI. Bivalirudin + GP IIb/IIIa (n=4,604).

249 views • 12 slides